Who is Richard Nanula and why is his appointment significant?

Richard Nanula is the Executive Vice President and Chief Financial Officer of Amgen Inc. His appointment to Boeing's Board of Directors is significant as it brings external financial leadership experience, particularly in a high-profile biotechnology company, to Boeing's oversight. His roles on the Audit and Finance Committees suggest a focus on financial governance and strategy.

Why did Boeing increase the size of its Board of Directors?

Boeing increased its Board size from eleven to twelve directors concurrently with the election of Richard Nanula. While the specific reasons are not detailed, this often indicates a strategic decision to accommodate new expertise, enhance committee capacity, or prepare for future needs. The addition of a new director with financial expertise likely played a key role in this decision.

Are there any conflicts of interest or related party transactions with the new director?

The filing explicitly states that there were no arrangements or understandings between Mr. Nanula and any other persons for his selection, and there are no disclosed related party transactions between Mr. Nanula and The Boeing Company. This indicates a clean appointment with no immediate conflicts of interest mentioned.

What is the effective date of these changes?

Richard Nanula's election as a director is effective January 1, 2005. The amendments to the By-Laws and the election itself were made on December 13, 2004.

BA/BA-PA 8-K: Leadership Changes & Corporate Changes

Summary

This 8-K filing from The Boeing Company on December 13, 2004, primarily announces two significant corporate governance changes. Firstly, Richard Nanula, Executive Vice President and Chief Financial Officer of Amgen Inc., was elected to Boeing's Board of Directors, effective January 1, 2005. His appointment, particularly his role on the Audit and Finance Committees, brings external financial expertise to the board. Secondly, the Board of Directors amended and restated the company's By-Laws to increase the authorized number of directors from eleven to twelve. This increase in board size, concurrent with the addition of Mr. Nanula, suggests a strategic move to enhance board oversight and potentially accommodate future growth or specialized needs. Investors should note the addition of a seasoned CFO to the board and the structural adjustment to accommodate this.

Key Highlights

1Richard Nanula, CFO of Amgen, elected to Boeing's Board of Directors effective January 1, 2005.
2Mr. Nanula appointed to the Company's Audit Committee and Finance Committee.
3Board size increased from eleven to twelve directors.
4By-Laws were amended and restated to reflect the increase in director positions.
5Mr. Nanula's election was recommended by the Governance, Organization and Nominating Committee.
6There were no disclosed arrangements or related party transactions concerning Mr. Nanula's appointment.

BOEING CO 8-K Report, Executive Changes (Dec 14, 2004)

Summary

Key Highlights

Frequently Asked Questions